Tandem Diabetes Care Inc (TNDM) income statement
TNDMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/3029% below fair value
$17.05−0.01 (-0.06%)
Close on Nov 18, 2026Market cap $1.19BP/E –Yield –
Tandem Diabetes Care Inc income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 56.0%
- Operating margin
- -4.4%
- Net margin
- -6.1%
- Return on equity, FY2025
- -97.9%
Financial strength
- Current ratio
- 3.18
- Debt to equity
- 4.62
- Debt to assets
- 52.2%
- Cash to current liabilities
- 24.8%
Valuation
- P/E ratio
- –
- Price to sales
- 1.14
- Price to book
- 9.10
- Dividend yield
- –
See a number that looks wrong?